The NF1 tumor suppressor regulates PD-L1 and immune evasion in melanoma.

Saved in:
Bibliographic Details
Title: The NF1 tumor suppressor regulates PD-L1 and immune evasion in melanoma.
Authors: Berry D; Rosalind and Morris Goodman Cancer Institute, McGill University, Montréal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montréal, QC H3G 1Y6, Canada., Moldoveanu D; Rosalind and Morris Goodman Cancer Institute, McGill University, Montréal, QC H3A 1A3, Canada; McGill University Health Centre, Montréal, QC H4A 3J1, Canada., Rajkumar S; Rosalind and Morris Goodman Cancer Institute, McGill University, Montréal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montréal, QC H3G 1Y6, Canada., Lajoie M; Rosalind and Morris Goodman Cancer Institute, McGill University, Montréal, QC H3A 1A3, Canada., Lin T; Rosalind and Morris Goodman Cancer Institute, McGill University, Montréal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montréal, QC H3G 1Y6, Canada., Tchelougou D; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM) and Institut du cancer de Montréal, Montréal, QC H2X 0A9, Canada; Département de Médecine, Faculté de Médecine, Université de Montréal, Montréal, QC H3T 1J4, Canada., Sakthivel S; Rosalind and Morris Goodman Cancer Institute, McGill University, Montréal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montréal, QC H3G 1Y6, Canada., Sharon I; Department of Biochemistry, McGill University, Montréal, QC H3G 1Y6, Canada., Bernard A; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM) and Institut du cancer de Montréal, Montréal, QC H2X 0A9, Canada., Pelletier S; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM) and Institut du cancer de Montréal, Montréal, QC H2X 0A9, Canada., Ripstein Y; Faculty of Medicine, University of Manitoba, Winnipeg, MB R3E 0W2, Canada., Spatz A; McGill University Health Centre, Montréal, QC H4A 3J1, Canada; Lady Davis Institute, McGill University, Montréal, QC H3T 1E1, Canada., Miller WH; Lady Davis Institute, McGill University, Montréal, QC H3T 1E1, Canada., Jamal R; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM) and Institut du cancer de Montréal, Montréal, QC H2X 0A9, Canada., Lapointe R; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM) and Institut du cancer de Montréal, Montréal, QC H2X 0A9, Canada; Département de Médecine, Faculté de Médecine, Université de Montréal, Montréal, QC H3T 1J4, Canada; Montreal Neurological Institute and Hospital, Montréal, QC H3A 2B4, Canada., Mes-Masson AM; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM) and Institut du cancer de Montréal, Montréal, QC H2X 0A9, Canada; Département de Médecine, Faculté de Médecine, Université de Montréal, Montréal, QC H3T 1J4, Canada., Petrecca K; Montreal Neurological Institute and Hospital, Montréal, QC H3A 2B4, Canada., Meguerditchian AN; McGill University Health Centre, Montréal, QC H4A 3J1, Canada., Richardson K; McGill University Health Centre, Montréal, QC H4A 3J1, Canada., Wang B; McGill University Health Centre, Montréal, QC H4A 3J1, Canada., Chergui M; McGill University Health Centre, Montréal, QC H4A 3J1, Canada., Guiot MC; McGill University Health Centre, Montréal, QC H4A 3J1, Canada., Watters K; McGill University Health Centre, Montréal, QC H4A 3J1, Canada., Stagg J; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM) and Institut du cancer de Montréal, Montréal, QC H2X 0A9, Canada; Département de Médecine, Faculté de Médecine, Université de Montréal, Montréal, QC H3T 1J4, Canada., Schmeing TM; Department of Biochemistry, McGill University, Montréal, QC H3G 1Y6, Canada., Rodier F; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM) and Institut du cancer de Montréal, Montréal, QC H2X 0A9, Canada; Department of Radiology, Radio-Oncology and Nuclear Medicine, Université de Montréal, Montreal, QC H3T 1J4, Canada., Turcotte S; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM) and Institut du cancer de Montréal, Montréal, QC H2X 0A9, Canada; Département de Médecine, Faculté de Médecine, Université de Montréal, Montréal, QC H3T 1J4, Canada., Mihalcioiu C; McGill University Health Centre, Montréal, QC H4A 3J1, Canada., Meterissian S; McGill University Health Centre, Montréal, QC H4A 3J1, Canada., Watson IR; Rosalind and Morris Goodman Cancer Institute, McGill University, Montréal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montréal, QC H3G 1Y6, Canada; McGill University Health Centre, Montréal, QC H4A 3J1, Canada. Electronic address: ian.watson2@mcgill.ca.
Source: Cell reports [Cell Rep] 2025 Mar 25; Vol. 44 (3), pp. 115365. Date of Electronic Publication: 2025 Mar 01.
Publication Type: Journal Article
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2211-1247
DOI:10.1016/j.celrep.2025.115365